Better Decisions in Clinical Trials Come from Better Data

Date
February 11, 2018

Service

Digital Transformation

Industry

clinical trials

Scientific endeavour continues its relentless pursuit of greater drug efficacy and speed of delivery.

Now more than ever it is crucial that clinical trials data is able to provide key decision-makers with insight just as quickly and effectively.

Rapid, actionable data is widely recognised as the basis for competitive advantage. Yet, many life sciences companies are still struggling with the sheer complexity of the data landscape.

In recent years we have seen a rapid explosion in the volume and variety of clinical trials data, with more complex trials, more data points, and the introduction of new data sources such as wearables and electronic health records.

The challenge it seems is that poor data quality, siloed data, lack of standardization or effective data management as well as a lack of well-designed visualization tools all can slow down decision-making. While the data may be there, the ability to use it effectively to optimize a clinical trial may not.

We’ve published a whitepaper addressing to help clinical organizations address exactly these challenges. Download it today for a step-by-step approach to managing your clinical data workflow.

About the author

Rob innes

Director and head of consultancy
Rob is the Director and Head of Consultancy at Wyoming and has over 20 years’ experience in digital transformation, using data to unlock value for numerous finance, life science and manufacturing organisations. Originally from a technology background in which he built applications for supply chain integration, customer self-service and customer acquisition, Rob is now primarily involved in helping organisations to do more with data-generating insights that are accessible to users regardless of their level of data expertise.

Latest insights

How Customer Experience and design work together

What is the pharmaceutical industry doing to achieve net-zero?